IP Group

Lumai specializes in fully optical computing technology, harnessing photonics and machine learning to accelerate artificial intelligence processing. Its innovative processor uses beams of light for rapid data processing, enhancing energy efficiency, and reducing operational expenses.

Alimetry is a health technology startup located in Auckland, New Zealand, focused on creating innovative solutions for diagnosing gastrointestinal (GI) disorders. The company has developed a symptom-tracking and real-time gastric mapping monitoring device that investigates gastric function. This device senses the underlying motility of the stomach to identify the causes of common symptoms such as abdominal pain, indigestion, nausea, and vomiting. By providing insights into GI health, Alimetry aims to enhance patient care and improve the management of gastrointestinal disorders.

Alesi Surgical Ltd. is a company based in Cardiff, United Kingdom, specializing in the development and commercialization of laparoscopic surgical smoke handling systems. Founded in 2009 as a spin-out from the Welsh Institute for Minimal Access Therapy, Alesi Surgical focuses on creating products that enhance the safety, efficiency, and outcomes of surgical procedures. Its innovative tools are portable and suitable for both laparoscopic and robot-assisted surgeries, utilizing electrostatic precipitation technology to eliminate surgical smoke and maintain a clear visual field during operations. The company distributes its products to hospitals across Europe, the Middle East, New Zealand, and Australia, leveraging its access to experienced surgeons and surgical trainers to identify challenges in surgical procedures and design effective solutions.

Microbiotica Limited is a biotechnology company based in Cambridge, United Kingdom, focused on discovering and developing human microbiome-based therapeutics. Founded in 2016, the company operates a platform that identifies gut bacteria associated with specific phenotypes from clinical trial samples. This advanced platform allows researchers to pinpoint gut bacteria with high precision, facilitating the development of live bacterial therapeutics and biomarkers. By enabling the identification of phenotypes prior to testing candidate bacteria in sophisticated human in vitro and in vivo models, Microbiotica aims to advance the understanding and application of microbiome science in therapeutic contexts.

Oxford Quantum Circuits develops quantum computing technology, aiming to tackle complex challenges such as climate change and drug discovery. Their fully functional quantum computer system enables businesses to explore innovative solutions and address global issues.

Deep Render is a London-based AI startup spun out from Imperial College London's Department of Computing. It develops AI-powered video and image compression technology that leverages deep learning, density estimation, unsupervised learning, and quantum techniques to improve compression efficiency. The company has proprietary, patented technology in media and biological image compression, with state-of-the-art results delivering at least a 50% efficiency gain over previous standards.

Intrinsic Semiconductor Technologies develops silicon oxide–based memristive devices with fully air-stable, CMOS-compatible technology. The company specializes in non-volatile and multilevel memory, and its platforms support hardware acceleration for machine learning and neuromorphic computing. Its memristive materials leverage common processing steps to enable integration in standard devices across advanced process nodes, facilitating operation at higher power, frequency, and temperature ranges. In addition to memory functions, the technology underpins low-power, cost-efficient semiconductors, including gallium nitride materials, suitable for diverse applications in data storage, processing, and next-generation computing architectures.

Quantum Motion Technologies is developing a universal quantum computer using Silicon-based CMOS processes. Its focus lies in creating scalable arrays of qubits, aiming to develop quantum computing architectures compatible with existing silicon processing methods.

Storm Therapeutics Limited is a biotechnology company based in Cambridge, United Kingdom, focused on discovering and developing small molecule drugs that target RNA-modifying enzymes for cancer treatment and other immune diseases. Incorporated in 2015 and previously known as Iceni Therapeutics Limited, the company utilizes its drug discovery and RNA analytics platform to modulate RNA modifying enzymes, identifying novel targets and first-in-class drug candidates. Storm Therapeutics aims to provide innovative therapies against RNA epigenetic targets, addressing various conditions including oncology, inflammation, viral infections, and central nervous system diseases.

Somalytics is a Seattle-based company that specializes in the development and commercialization of innovative miniature sensors for applications such as eye tracking, human-machine interfaces, wearables, and industrial safety. Founded in 2021, the company has created the world's first paper-composite capacitive sensor, which is ultra-thin, energy-efficient, and potentially disposable. These carbon nanotube-based sensors enhance sensitivity and aim to replace traditional cameras and sensors in various devices, thereby improving the overall human experience through advanced technology.

Nexeon is an international developer and manufacturer of silicon-based anode materials for rechargeable lithium-ion batteries. The company focuses on silicon anodes to increase energy density, enabling lighter, smaller, and more cost-efficient batteries for a range of applications including electric vehicles and consumer electronics, as well as other sectors that require high-performance energy storage. Headquarters are in Oxfordshire, United Kingdom, and the company maintains operations in Japan, with a history dating back to 2006. By replacing traditional graphite anodes, Nexeon's materials aim to enhance battery performance while reducing overall carbon footprint.

Hysata is focused on advancing hydrogen electrolyzer technology to facilitate the production of green hydrogen, aiming to significantly reduce costs to below $2 per kilogram. This innovative approach is rooted in research from the University of Wollongong's ARC Centre of Excellence for Electromaterials Science, led by Professor Gerry Swiegers. The company’s electrolyzers operate by using electricity to separate water into hydrogen and oxygen, thereby supporting the transition from fossil fuels to sustainable energy sources. Hysata's initiatives are designed to play a crucial role in helping businesses achieve net-zero emissions and accelerate the global move towards environmentally friendly energy solutions.

Alimetry is a health technology startup located in Auckland, New Zealand, focused on creating innovative solutions for diagnosing gastrointestinal (GI) disorders. The company has developed a symptom-tracking and real-time gastric mapping monitoring device that investigates gastric function. This device senses the underlying motility of the stomach to identify the causes of common symptoms such as abdominal pain, indigestion, nausea, and vomiting. By providing insights into GI health, Alimetry aims to enhance patient care and improve the management of gastrointestinal disorders.

Helio Display Materials is a developer of innovative perovskite-based materials aimed at enhancing display technology. The company focuses on creating materials that enable brighter and more colorful displays while significantly reducing power consumption. By leveraging metal halide perovskites, which can be synthesized using low-temperature processes and earth-abundant precursor materials, Helio aims to produce vibrant and efficient light-emitting technologies for televisions and displays. The company emphasizes collaboration with scientific and industry experts to expedite research and development, ensuring a strong scientific foundation for its intellectual property. Helio's mission is to improve display performance and efficiency, ultimately providing a superior visual experience.

First Light Fusion Limited is a UK-based company that specializes in researching advanced implosion processes aimed at electricity generation through inertial confinement fusion. Founded in 2011 as a spin-out from the University of Oxford, the company focuses on harnessing fundamental physics to explore various innovative energy generation methods. It employs a team of engineers and physicists who engage in theoretical analysis, detailed numerical simulations, and experimental validation to develop new energy sources. First Light Fusion collaborates closely with several academic institutions, including the University of Oxford, Warwick University, University College London, and Imperial College London. The company, originally named Oxyntix Ltd., rebranded in June 2014 to reflect its focus on fusion energy research.

Microbiotica Limited is a biotechnology company based in Cambridge, United Kingdom, focused on discovering and developing human microbiome-based therapeutics. Founded in 2016, the company operates a platform that identifies gut bacteria associated with specific phenotypes from clinical trial samples. This advanced platform allows researchers to pinpoint gut bacteria with high precision, facilitating the development of live bacterial therapeutics and biomarkers. By enabling the identification of phenotypes prior to testing candidate bacteria in sophisticated human in vitro and in vivo models, Microbiotica aims to advance the understanding and application of microbiome science in therapeutic contexts.

Lumai specializes in fully optical computing technology, harnessing photonics and machine learning to accelerate artificial intelligence processing. Its innovative processor uses beams of light for rapid data processing, enhancing energy efficiency, and reducing operational expenses.

Monolith AI Limited is a software company based in London, United Kingdom, founded in 2016. The company specializes in developing algorithms that integrate engineering simulations with machine learning techniques to enhance the engineering design process. By leveraging existing simulation and test data, Monolith AI enables engineers to predict the behavior of new products more accurately, thereby optimizing research and development efforts. This approach reduces the need for extensive simulations, tests, and prototypes, allowing companies to accelerate product development and improve overall product quality. Monolith AI was previously known as UQuant Limited until it rebranded in June 2018.

Alesi Surgical Ltd. is a company based in Cardiff, United Kingdom, specializing in the development and commercialization of laparoscopic surgical smoke handling systems. Founded in 2009 as a spin-out from the Welsh Institute for Minimal Access Therapy, Alesi Surgical focuses on creating products that enhance the safety, efficiency, and outcomes of surgical procedures. Its innovative tools are portable and suitable for both laparoscopic and robot-assisted surgeries, utilizing electrostatic precipitation technology to eliminate surgical smoke and maintain a clear visual field during operations. The company distributes its products to hospitals across Europe, the Middle East, New Zealand, and Australia, leveraging its access to experienced surgeons and surgical trainers to identify challenges in surgical procedures and design effective solutions.

MOBILion Systems designs and commercializes SLIM-based ion mobility technology that enables lossless ion transfer and manipulation for separating and detecting biomolecules that are challenging to distinguish with conventional instruments. The company's systems provide high sensitivity, resolution, and throughput to analyze proteins, peptides, metabolites, glycans, and lipids, supporting biomarker discovery, early disease detection, and accelerated biologics development. By enabling rapid analysis of population-scale samples, the technology aims to improve diagnostics, monitor treatment, and advance precision medicine.

Oxford Nanopore Technologies Limited is a biotechnology company specializing in the development and commercialization of nanopore-based sequencing technology for the analysis of DNA, RNA, proteins, and small molecules. Its innovative product lineup includes the portable MinION device, the benchtop PromethION, and the GridION system, all of which enable real-time data streaming and scalable sequencing for a variety of applications in scientific research, personalized medicine, environmental monitoring, and agriculture. The Flongle offers smaller, on-demand sequencing solutions, catering to users requiring rapid insights. Operating in over 80 countries, Oxford Nanopore's technology is designed for accessibility and ease of use, featuring straightforward library preparation and automated solutions. The company maintains a robust patent portfolio, supporting its ongoing research and development in both biological and solid-state nanopore technologies. Founded in 2005 and based in Oxford, United Kingdom, Oxford Nanopore Technologies also has offices in multiple countries, including the United States, China, and Germany.

Intrinsic Semiconductor Technologies develops silicon oxide–based memristive devices with fully air-stable, CMOS-compatible technology. The company specializes in non-volatile and multilevel memory, and its platforms support hardware acceleration for machine learning and neuromorphic computing. Its memristive materials leverage common processing steps to enable integration in standard devices across advanced process nodes, facilitating operation at higher power, frequency, and temperature ranges. In addition to memory functions, the technology underpins low-power, cost-efficient semiconductors, including gallium nitride materials, suitable for diverse applications in data storage, processing, and next-generation computing architectures.

Econic Technologies Ltd. is a chemical technology company based in Macclesfield, United Kingdom, specializing in the development of innovative processes to convert carbon dioxide and epoxides into valuable polymers and polyurethanes. Founded in 2011, the company leverages catalyst chemistry to transform waste CO2 into commercially viable products, thereby reducing dependence on fossil fuels and providing environmental benefits. Econic's product offerings include polycarbonates and polycarbonate polyols, which are utilized in various applications such as mattresses, insulation, footwear, packaging, and construction materials. Additionally, the company produces glues and coatings for industrial uses. With patented catalyst technologies and a skilled team of scientists and engineers, Econic Technologies operates from a state-of-the-art facility at Alderley Park, focusing on turning scientific advancements into practical solutions for the plastics industry while addressing environmental challenges.

Alimetry is a health technology startup located in Auckland, New Zealand, focused on creating innovative solutions for diagnosing gastrointestinal (GI) disorders. The company has developed a symptom-tracking and real-time gastric mapping monitoring device that investigates gastric function. This device senses the underlying motility of the stomach to identify the causes of common symptoms such as abdominal pain, indigestion, nausea, and vomiting. By providing insights into GI health, Alimetry aims to enhance patient care and improve the management of gastrointestinal disorders.

Augmented Bionics is focused on creating a non-surgical alternative to cochlear implants for individuals with severe to profound hearing loss. The company leverages Transcranial Magnetic Stimulation (TMS), a safe and FDA-approved neuromodulation technology, to develop its innovative device. Unlike traditional hearing aids, which are ineffective for this demographic, Augmented Bionics' solution offers the convenience of a wearable device similar to headphones while providing the functionality of a cochlear implant. This approach aims to reduce barriers to access, such as the risks, high costs, and specialist requirements associated with surgical implants. By addressing the needs of the over 70 million people affected by profound hearing loss, Augmented Bionics seeks to transform the treatment landscape and enhance the quality of life for its users.

MOBILion Systems designs and commercializes SLIM-based ion mobility technology that enables lossless ion transfer and manipulation for separating and detecting biomolecules that are challenging to distinguish with conventional instruments. The company's systems provide high sensitivity, resolution, and throughput to analyze proteins, peptides, metabolites, glycans, and lipids, supporting biomarker discovery, early disease detection, and accelerated biologics development. By enabling rapid analysis of population-scale samples, the technology aims to improve diagnostics, monitor treatment, and advance precision medicine.

Oxford Ionics specializes in advanced quantum computing systems, focusing on trapped-ion technology. This enables scalable, efficient quantum chips produced via standard semiconductor methods, facilitating advancements in quantum computing and enhancing computational capabilities for complex problems.

IBEX Innovations develops innovative X-ray detector technology that generates high sensitivity materials information from standard detectors. Its core product, IBEX multi absorption plate (MAP) technology, integrates detectors to provide material insights while maintaining speed and resolution characteristics of underlying sensors. Applications include bone mineral density measurement, electronics inspection, food safety, and security screening.

Quantum Motion Technologies is developing a universal quantum computer using Silicon-based CMOS processes. Its focus lies in creating scalable arrays of qubits, aiming to develop quantum computing architectures compatible with existing silicon processing methods.

Instrumems Inc. is a technology company based in Los Altos, California, specializing in the development of innovative nano-wire sensors. Founded in 2016, the company focuses on creating a versatile sensing platform capable of measuring temperature, flow velocity, and humidity. Instrumems' sensors are designed to be faster, more cost-effective, and smaller in size compared to traditional measurement techniques. Their technology is increasingly relevant in various sectors, including aerospace, automotive, and environmental monitoring, facilitating applications such as real-time weather tracking and distributed climate monitoring. The company's multi-sensor solutions leverage high-resolution and high-frequency measurement capabilities, providing clients with industry-leading response times, accuracy, and ultra-low power consumption.

MOBILion Systems designs and commercializes SLIM-based ion mobility technology that enables lossless ion transfer and manipulation for separating and detecting biomolecules that are challenging to distinguish with conventional instruments. The company's systems provide high sensitivity, resolution, and throughput to analyze proteins, peptides, metabolites, glycans, and lipids, supporting biomarker discovery, early disease detection, and accelerated biologics development. By enabling rapid analysis of population-scale samples, the technology aims to improve diagnostics, monitor treatment, and advance precision medicine.

Inflowmatix designs and implements electronic systems that provide water flow and system health analytics to water utilities worldwide. Its system optimizes water supply networks by monitoring fluid dynamics, improving leakage management, and extending the life of infrastructure.

CareAlign is a developer of a real-time data system that enhances the management and coordination of clinical care for clinicians. The company offers an intuitive, patient-centric task management tool that allows healthcare professionals to assign tasks, set deadlines, and categorize them based on urgency. By aggregating data from multiple sources, CareAlign provides a comprehensive and clinically intuitive display of patients' clinical status, facilitating better understanding and decision-making in patient care. This system aims to streamline workflows and improve communication among clinicians, ultimately enhancing the quality of care delivered to patients.

WaveOptics, Ltd. is a designer and manufacturer of advanced augmented reality display technology, specializing in diffractive waveguides for wearable devices. Founded in 2014 and headquartered in Abingdon-on-Thames, United Kingdom, the company focuses on providing key optical components for augmented reality applications. WaveOptics employs patented technology that utilizes waveguide holography and photonic crystals to create lightweight, high-performance displays. Their innovative designs feature a high field of view and full RGB color, allowing for an enriched user experience without the bulk typically associated with traditional augmented reality systems. The company has established strategic partnerships with leading firms such as Compal, Wistron, and Plessey to enhance its product offerings and market reach.

IBEX Innovations develops innovative X-ray detector technology that generates high sensitivity materials information from standard detectors. Its core product, IBEX multi absorption plate (MAP) technology, integrates detectors to provide material insights while maintaining speed and resolution characteristics of underlying sensors. Applications include bone mineral density measurement, electronics inspection, food safety, and security screening.

Storm Therapeutics Limited is a biotechnology company based in Cambridge, United Kingdom, focused on discovering and developing small molecule drugs that target RNA-modifying enzymes for cancer treatment and other immune diseases. Incorporated in 2015 and previously known as Iceni Therapeutics Limited, the company utilizes its drug discovery and RNA analytics platform to modulate RNA modifying enzymes, identifying novel targets and first-in-class drug candidates. Storm Therapeutics aims to provide innovative therapies against RNA epigenetic targets, addressing various conditions including oncology, inflammation, viral infections, and central nervous system diseases.

Inivata Limited is a clinical cancer genomics company based in Cambridge, United Kingdom, that specializes in the analysis of circulating tumor DNA (ctDNA) to enhance cancer testing and treatment. Founded in 2014, Inivata has developed TAm-Seq technology, which enables the detection and analysis of genomic material from a patient's cell-free ctDNA, collected through non-invasive blood samples. This innovative approach, known as liquid biopsy, provides a significant advancement over traditional invasive biopsies by allowing for easier detection, monitoring, and treatment of cancer. Inivata's platform aims to assist oncologists in making informed treatment decisions by improving the understanding of cancer dynamics, including monitoring treatment responses and detecting relapses. The company has established a strategic collaboration with NeoGenomics, Inc. to further its mission in the field of cancer genomics.

WaveOptics, Ltd. is a designer and manufacturer of advanced augmented reality display technology, specializing in diffractive waveguides for wearable devices. Founded in 2014 and headquartered in Abingdon-on-Thames, United Kingdom, the company focuses on providing key optical components for augmented reality applications. WaveOptics employs patented technology that utilizes waveguide holography and photonic crystals to create lightweight, high-performance displays. Their innovative designs feature a high field of view and full RGB color, allowing for an enriched user experience without the bulk typically associated with traditional augmented reality systems. The company has established strategic partnerships with leading firms such as Compal, Wistron, and Plessey to enhance its product offerings and market reach.

IBEX Innovations develops innovative X-ray detector technology that generates high sensitivity materials information from standard detectors. Its core product, IBEX multi absorption plate (MAP) technology, integrates detectors to provide material insights while maintaining speed and resolution characteristics of underlying sensors. Applications include bone mineral density measurement, electronics inspection, food safety, and security screening.

Garrison Technology Limited, established in London, UK, in 2014, specializes in enterprise cybersecurity solutions. The company focuses on developing innovative anti-malware technology designed to efficiently mitigate high-impact internet-borne targeted attacks, a significant threat to modern organizations. Garrison's unique approach enables secure internet connectivity, enhances user experience, and ensures scalability for enterprises.

Dukosi Ltd is a company that specializes in the design, development, and manufacture of advanced battery management systems, primarily serving the automotive industry. Founded in 2003 and located in Edinburgh, United Kingdom, Dukosi offers innovative cell sensor products tailored for hybrid, plug-in hybrid, and electric vehicles, as well as electric bicycles and mobility solutions. The company's technology enables real-time monitoring of individual battery cell health, contributing to enhanced performance and longevity. Dukosi's solutions are aimed at providing reliable and renewable energy sources for vehicles, transport networks, and various applications, thereby supporting the transition to cleaner energy technologies.

Silicon Microgravity is a Cambridge, United Kingdom based sensor technology company that develops microelectromechanical systems for oil and gas reservoir surveillance and other applications. Its gravity sensors deliver high-sensitivity gravity data and ultra-low-frequency seismic data from boreholes, enabling precise density measurements deep in reservoirs and real-time reservoir management. The technology originated as a Cambridge University spin-out, developed with support from BP and Innovate UK, and has broader uses in navigation and stabilization of intelligent systems across commercial, industrial, and military sectors. The company aims to improve efficiency, reduce costs, and support safety and environmental goals in hydrocarbon production.

OxSyBio Ltd. is a biotechnology company based in London, United Kingdom, specializing in the development of advanced 3D printing techniques for creating tissue-like and functional tissues intended for medical research and clinical applications. Founded in 2014, the company focuses on innovative methods that utilize three-dimensional networks of lipid monolayer aqueous droplets, which can conduct electrical signals along designated pathways and self-fold into intricate structures. These engineered tissues aim to facilitate organ repair or replacement, supporting precision medicine initiatives. The technology builds upon pioneering research from Professor Hagan Bayley's group at the University of Oxford, emphasizing the integration of chemical and synthetic biology in the field of regenerative medicine.

Econic Technologies Ltd. is a chemical technology company based in Macclesfield, United Kingdom, specializing in the development of innovative processes to convert carbon dioxide and epoxides into valuable polymers and polyurethanes. Founded in 2011, the company leverages catalyst chemistry to transform waste CO2 into commercially viable products, thereby reducing dependence on fossil fuels and providing environmental benefits. Econic's product offerings include polycarbonates and polycarbonate polyols, which are utilized in various applications such as mattresses, insulation, footwear, packaging, and construction materials. Additionally, the company produces glues and coatings for industrial uses. With patented catalyst technologies and a skilled team of scientists and engineers, Econic Technologies operates from a state-of-the-art facility at Alderley Park, focusing on turning scientific advancements into practical solutions for the plastics industry while addressing environmental challenges.

Quantum Motion Technologies is developing a universal quantum computer using Silicon-based CMOS processes. Its focus lies in creating scalable arrays of qubits, aiming to develop quantum computing architectures compatible with existing silicon processing methods.

Touchstone Innovations is a venture capital firm that focuses on creating, building, and investing in pioneering technology companies emerging from exceptional scientific research in the 'Golden Triangle' of London, Cambridge, and Oxford. Established in 1986, the firm employs a comprehensive strategy that encompasses the entire process from idea generation to intellectual property protection, company formation, seed funding, incubation, and scale-up. By providing continuous investment from start-up to scale-up, Touchstone Innovations supports scientists and entrepreneurs in commercializing their ideas through licensing and recruitment of top management teams. The firm has a proven track record of leveraging early-stage research into high-quality, well-managed businesses, maintaining active involvement with its portfolio companies throughout their lifecycle. With a commitment to de-risking investment, Touchstone Innovations has facilitated over £1.5 billion in funding to drive technological innovation in the UK. In 2017, the firm was acquired by IP Group plc, further expanding its capabilities in the investment landscape.

Ionix Advanced Technologies designs and manufactures high-temperature piezoelectric devices and materials, offering sensors, actuators and transducers based on novel high-temperature piezoelectric materials and anisotropic ceramics to reduce ultrasonic crosstalk and improve acoustic transmission. It serves industrial processes in aerospace, oil and gas, nuclear power, automotive, and ultrasound and nondestructive testing markets, focusing on high-performance systems that operate reliably in extreme environments, including high temperatures and radiation. The company enables continuous monitoring and safer, more efficient operation of equipment. Founded in 2011 and based in Leeds, United Kingdom.

Eight19 Limited, based in Cambridge, United Kingdom, specializes in the development and manufacture of organic photovoltaic (OPV) modules designed for lightweight solar panels. Founded in 2010, the company focuses on providing energy harvesting solutions for various applications, including indoor, outdoor, and off-grid environments. Eight19's innovative use of roll-to-roll manufacturing processes and solution-based organic materials allows for cost-effective scaling of its technology. Their products are particularly suited for the internet of things, wireless devices, and portable electronics, offering benefits such as flexibility, thinness, and robustness. The company also produces integrated demonstration units, including Bluetooth-connected temperature and light sensors powered by its OPV modules, reinforcing its commitment to advancing sustainable energy solutions.

Creavo Medical Technologies Ltd. is a UK-based medical device company focused on developing innovative imaging technologies for acute medical settings. Incorporated in 2014, the company has its headquarters in Coventry and additional facilities in Leeds. Creavo specializes in creating portable, battery-powered devices that utilize magnetocardiography to detect heart-related issues, such as acute coronary syndromes and ischemia, directly at the patient's bedside. Founded by a team of clinical, research, and business experts, the company aims to improve diagnostic techniques and enhance patient outcomes in healthcare settings. Creavo Medical Technologies was previously known as Quantum Imaging Limited before rebranding in September 2016.

Alesi Surgical Ltd. is a company based in Cardiff, United Kingdom, specializing in the development and commercialization of laparoscopic surgical smoke handling systems. Founded in 2009 as a spin-out from the Welsh Institute for Minimal Access Therapy, Alesi Surgical focuses on creating products that enhance the safety, efficiency, and outcomes of surgical procedures. Its innovative tools are portable and suitable for both laparoscopic and robot-assisted surgeries, utilizing electrostatic precipitation technology to eliminate surgical smoke and maintain a clear visual field during operations. The company distributes its products to hospitals across Europe, the Middle East, New Zealand, and Australia, leveraging its access to experienced surgeons and surgical trainers to identify challenges in surgical procedures and design effective solutions.

SAW DX Ltd is a technology development company based in Glasgow, United Kingdom, that specializes in designing and manufacturing point-of-care (POC) diagnostic devices. The company leverages innovative Acoustic-Flow technology, which utilizes surface acoustic waves to drive diagnostic tests by manipulating fluid movement and microstructures on disposable chips. This approach allows for on-chip sample processing without the need for preprocessing, streamlining the diagnostic process. SAW DX's product offerings include prototypes for diagnosing sexually transmitted infections, demonstrator readers and cartridges for tuberculosis assays, and platforms for enriching parasites and performing molecular detection with low-cost disposable chips. The company primarily serves life sciences and diagnostics organizations seeking to enhance their diagnostic capabilities through advanced POC solutions. Incorporated in 2013, SAW DX aims to provide faster, more efficient, and cost-effective diagnostic methods for infectious diseases.

Dukosi Ltd is a company that specializes in the design, development, and manufacture of advanced battery management systems, primarily serving the automotive industry. Founded in 2003 and located in Edinburgh, United Kingdom, Dukosi offers innovative cell sensor products tailored for hybrid, plug-in hybrid, and electric vehicles, as well as electric bicycles and mobility solutions. The company's technology enables real-time monitoring of individual battery cell health, contributing to enhanced performance and longevity. Dukosi's solutions are aimed at providing reliable and renewable energy sources for vehicles, transport networks, and various applications, thereby supporting the transition to cleaner energy technologies.

Parkwalk Advisors is a London-based venture capital firm that focuses on UK technology companies with IP backing, primarily those spun out from UK universities. The firm invests across seed to growth stages, including late-stage rounds, and is stage-agnostic, aiming to support unlisted companies with freedom to operate. It concentrates on companies originating from university research, especially in Cambridge and across the UK, and targets sectors such as healthcare, energy, materials, technology, artificial intelligence, big data, life sciences, cleantech, medtech, quantum computing, and the apps ecosystem. Typical investments range from about £0.3 million to £10 million, with capital structures kept in a single share class, and the firm may provide equity or debt financings. Investments are generally planned over a three- to eight-year horizon.

Microbiotica Limited is a biotechnology company based in Cambridge, United Kingdom, focused on discovering and developing human microbiome-based therapeutics. Founded in 2016, the company operates a platform that identifies gut bacteria associated with specific phenotypes from clinical trial samples. This advanced platform allows researchers to pinpoint gut bacteria with high precision, facilitating the development of live bacterial therapeutics and biomarkers. By enabling the identification of phenotypes prior to testing candidate bacteria in sophisticated human in vitro and in vivo models, Microbiotica aims to advance the understanding and application of microbiome science in therapeutic contexts.

Oxford Nanopore Technologies Limited is a biotechnology company specializing in the development and commercialization of nanopore-based sequencing technology for the analysis of DNA, RNA, proteins, and small molecules. Its innovative product lineup includes the portable MinION device, the benchtop PromethION, and the GridION system, all of which enable real-time data streaming and scalable sequencing for a variety of applications in scientific research, personalized medicine, environmental monitoring, and agriculture. The Flongle offers smaller, on-demand sequencing solutions, catering to users requiring rapid insights. Operating in over 80 countries, Oxford Nanopore's technology is designed for accessibility and ease of use, featuring straightforward library preparation and automated solutions. The company maintains a robust patent portfolio, supporting its ongoing research and development in both biological and solid-state nanopore technologies. Founded in 2005 and based in Oxford, United Kingdom, Oxford Nanopore Technologies also has offices in multiple countries, including the United States, China, and Germany.

Uniphy specializes in developing optical and hybrid touchscreen technology for creating intelligent, free-form touch surfaces. Their innovative platform enables original equipment manufacturers (OEMs) to integrate accurate touch detection alongside mechanical dials and control knobs, offering unmatched design flexibility, diverse human-machine interface features, and sustainable economic solutions.

Instrumems Inc. is a technology company based in Los Altos, California, specializing in the development of innovative nano-wire sensors. Founded in 2016, the company focuses on creating a versatile sensing platform capable of measuring temperature, flow velocity, and humidity. Instrumems' sensors are designed to be faster, more cost-effective, and smaller in size compared to traditional measurement techniques. Their technology is increasingly relevant in various sectors, including aerospace, automotive, and environmental monitoring, facilitating applications such as real-time weather tracking and distributed climate monitoring. The company's multi-sensor solutions leverage high-resolution and high-frequency measurement capabilities, providing clients with industry-leading response times, accuracy, and ultra-low power consumption.

Stratium Limited is a manufacturer of mid-infrared quantum cascade lasers (QCL) based in Cardiff, United Kingdom. Established in 2015, the company specializes in providing compound semiconductor lasers to original equipment manufacturers (OEM) for various commercial applications. Stratium's QCLs support critical functions in environmental monitoring, vehicle emission tracking, vehicle collision avoidance, breath diagnostics, and petrochemical process oversight. The lasers are designed to deliver precise mid-infrared emissions essential for advanced gas analysis, utilizing innovative wavelength selection technology that enhances their compactness, stability, and performance. These features make Stratium's products suitable for sensitive detection of molecular species employing techniques such as cavity ring-down spectroscopy, cavity enhanced absorption spectrometry, and photoacoustic spectroscopy, enabling clients to effectively monitor airborne substances.

Dukosi Ltd is a company that specializes in the design, development, and manufacture of advanced battery management systems, primarily serving the automotive industry. Founded in 2003 and located in Edinburgh, United Kingdom, Dukosi offers innovative cell sensor products tailored for hybrid, plug-in hybrid, and electric vehicles, as well as electric bicycles and mobility solutions. The company's technology enables real-time monitoring of individual battery cell health, contributing to enhanced performance and longevity. Dukosi's solutions are aimed at providing reliable and renewable energy sources for vehicles, transport networks, and various applications, thereby supporting the transition to cleaner energy technologies.

SpecifiedBy operates a database and specification library for building products and materials, connecting manufacturers with specifiers and enabling professionals to search, compare, and manage product information. The platform aggregates relevant data to support decision-making and aims to streamline the product selection process by offering modern search tools and information management features. It supports online research for specifiers and helps manufacturers present their offerings more effectively, with the goal of making it quicker and easier to identify suitable products for any project, regardless of brand or reputation.

Seren Photonics Limited specializes in the development and manufacture of semi-polar and non-polar Gallium Nitride (GaN) templates, which are essential for light-emitting diodes (LEDs), lasers, vertical-cavity surface-emitting lasers (VCSELs), and power switches. Based in Bridgend, United Kingdom, the company employs a proprietary manufacturing process to produce these templates, specifically growing semi-polar GaN on m-plane sapphire and non-polar GaN on r-plane sapphire. Their innovative technology significantly enhances light intensity in high-brightness LEDs, achieving increases in light generation ranging from 100% to 900% compared to untreated diodes. Founded in 2009, Seren Photonics has positioned itself to serve various lighting markets, including backlighting for laptops and televisions, signage, and architectural lighting. As of November 2016, it operates as a subsidiary of Fusion IP Sheffield Limited.

First Light Fusion Limited is a UK-based company that specializes in researching advanced implosion processes aimed at electricity generation through inertial confinement fusion. Founded in 2011 as a spin-out from the University of Oxford, the company focuses on harnessing fundamental physics to explore various innovative energy generation methods. It employs a team of engineers and physicists who engage in theoretical analysis, detailed numerical simulations, and experimental validation to develop new energy sources. First Light Fusion collaborates closely with several academic institutions, including the University of Oxford, Warwick University, University College London, and Imperial College London. The company, originally named Oxyntix Ltd., rebranded in June 2014 to reflect its focus on fusion energy research.

Oxford Nanopore Technologies Limited is a biotechnology company specializing in the development and commercialization of nanopore-based sequencing technology for the analysis of DNA, RNA, proteins, and small molecules. Its innovative product lineup includes the portable MinION device, the benchtop PromethION, and the GridION system, all of which enable real-time data streaming and scalable sequencing for a variety of applications in scientific research, personalized medicine, environmental monitoring, and agriculture. The Flongle offers smaller, on-demand sequencing solutions, catering to users requiring rapid insights. Operating in over 80 countries, Oxford Nanopore's technology is designed for accessibility and ease of use, featuring straightforward library preparation and automated solutions. The company maintains a robust patent portfolio, supporting its ongoing research and development in both biological and solid-state nanopore technologies. Founded in 2005 and based in Oxford, United Kingdom, Oxford Nanopore Technologies also has offices in multiple countries, including the United States, China, and Germany.

Ionix Advanced Technologies designs and manufactures high-temperature piezoelectric devices and materials, offering sensors, actuators and transducers based on novel high-temperature piezoelectric materials and anisotropic ceramics to reduce ultrasonic crosstalk and improve acoustic transmission. It serves industrial processes in aerospace, oil and gas, nuclear power, automotive, and ultrasound and nondestructive testing markets, focusing on high-performance systems that operate reliably in extreme environments, including high temperatures and radiation. The company enables continuous monitoring and safer, more efficient operation of equipment. Founded in 2011 and based in Leeds, United Kingdom.

Anacail Limited is a technology company based in Glasgow, United Kingdom, founded in 2010. It specializes in the development of innovative ozone-based systems for the sterilization of products within sealed packaging. Anacail's technology generates ozone directly in the final product packaging, effectively oxidizing surface contaminants and eliminating microorganisms without leaving any residual chemicals. This approach not only enhances food safety and extends shelf life but also addresses handling and safety concerns typically associated with ozone use. The company provides equipment for integration into food processing lines, as well as devices for medical sterilization, offering a safe and efficient method for achieving chemical-free sterilization of packaged goods.

Relitect Limited is a technology company based in Motherwell, United Kingdom, focused on developing innovative diagnostic solutions for the life sciences industry. Founded in 2014, Relitect specializes in a novel assay platform that enables label-free electrochemical detection of binding events. This proprietary technology allows for the highly sensitive analysis of proteins, small molecules, and nucleic acids, making it suitable for clinical diagnostics and research applications. By utilizing small sample volumes and a multiplexed format, Relitect's technology minimizes sample interference and eliminates the potential for cross-talk between labeled reagents, enhancing the accuracy of biomarker detection.

Dukosi Ltd is a company that specializes in the design, development, and manufacture of advanced battery management systems, primarily serving the automotive industry. Founded in 2003 and located in Edinburgh, United Kingdom, Dukosi offers innovative cell sensor products tailored for hybrid, plug-in hybrid, and electric vehicles, as well as electric bicycles and mobility solutions. The company's technology enables real-time monitoring of individual battery cell health, contributing to enhanced performance and longevity. Dukosi's solutions are aimed at providing reliable and renewable energy sources for vehicles, transport networks, and various applications, thereby supporting the transition to cleaner energy technologies.

Eight19 Limited, based in Cambridge, United Kingdom, specializes in the development and manufacture of organic photovoltaic (OPV) modules designed for lightweight solar panels. Founded in 2010, the company focuses on providing energy harvesting solutions for various applications, including indoor, outdoor, and off-grid environments. Eight19's innovative use of roll-to-roll manufacturing processes and solution-based organic materials allows for cost-effective scaling of its technology. Their products are particularly suited for the internet of things, wireless devices, and portable electronics, offering benefits such as flexibility, thinness, and robustness. The company also produces integrated demonstration units, including Bluetooth-connected temperature and light sensors powered by its OPV modules, reinforcing its commitment to advancing sustainable energy solutions.

Perpetuum Ltd. is a company based in Southampton, United Kingdom, that specializes in the engineering, manufacturing, and commercialization of electromagnetic vibration harvesting micro generators. Founded in 2004 as a technology spin-off from the University of Southampton, Perpetuum has developed innovative self-powered wireless sensor solutions designed for condition monitoring in various industries, including rail, oil and gas, chemicals, and power generation. Its flagship products convert mechanical vibration into electrical energy, allowing for the operation of autonomous, maintenance-free wireless sensor nodes that transmit critical data on equipment health and performance. Perpetuum is recognized as the global leader in vibration energy harvesting, continually advancing the practical applications of this technology to enhance operational efficiency and safety in industrial environments.

Oxford Nanopore Technologies Limited is a biotechnology company specializing in the development and commercialization of nanopore-based sequencing technology for the analysis of DNA, RNA, proteins, and small molecules. Its innovative product lineup includes the portable MinION device, the benchtop PromethION, and the GridION system, all of which enable real-time data streaming and scalable sequencing for a variety of applications in scientific research, personalized medicine, environmental monitoring, and agriculture. The Flongle offers smaller, on-demand sequencing solutions, catering to users requiring rapid insights. Operating in over 80 countries, Oxford Nanopore's technology is designed for accessibility and ease of use, featuring straightforward library preparation and automated solutions. The company maintains a robust patent portfolio, supporting its ongoing research and development in both biological and solid-state nanopore technologies. Founded in 2005 and based in Oxford, United Kingdom, Oxford Nanopore Technologies also has offices in multiple countries, including the United States, China, and Germany.

Seren Photonics Limited specializes in the development and manufacture of semi-polar and non-polar Gallium Nitride (GaN) templates, which are essential for light-emitting diodes (LEDs), lasers, vertical-cavity surface-emitting lasers (VCSELs), and power switches. Based in Bridgend, United Kingdom, the company employs a proprietary manufacturing process to produce these templates, specifically growing semi-polar GaN on m-plane sapphire and non-polar GaN on r-plane sapphire. Their innovative technology significantly enhances light intensity in high-brightness LEDs, achieving increases in light generation ranging from 100% to 900% compared to untreated diodes. Founded in 2009, Seren Photonics has positioned itself to serve various lighting markets, including backlighting for laptops and televisions, signage, and architectural lighting. As of November 2016, it operates as a subsidiary of Fusion IP Sheffield Limited.

OxSyBio Ltd. is a biotechnology company based in London, United Kingdom, specializing in the development of advanced 3D printing techniques for creating tissue-like and functional tissues intended for medical research and clinical applications. Founded in 2014, the company focuses on innovative methods that utilize three-dimensional networks of lipid monolayer aqueous droplets, which can conduct electrical signals along designated pathways and self-fold into intricate structures. These engineered tissues aim to facilitate organ repair or replacement, supporting precision medicine initiatives. The technology builds upon pioneering research from Professor Hagan Bayley's group at the University of Oxford, emphasizing the integration of chemical and synthetic biology in the field of regenerative medicine.

Creavo Medical Technologies Ltd. is a UK-based medical device company focused on developing innovative imaging technologies for acute medical settings. Incorporated in 2014, the company has its headquarters in Coventry and additional facilities in Leeds. Creavo specializes in creating portable, battery-powered devices that utilize magnetocardiography to detect heart-related issues, such as acute coronary syndromes and ischemia, directly at the patient's bedside. Founded by a team of clinical, research, and business experts, the company aims to improve diagnostic techniques and enhance patient outcomes in healthcare settings. Creavo Medical Technologies was previously known as Quantum Imaging Limited before rebranding in September 2016.

SpecifiedBy operates a database and specification library for building products and materials, connecting manufacturers with specifiers and enabling professionals to search, compare, and manage product information. The platform aggregates relevant data to support decision-making and aims to streamline the product selection process by offering modern search tools and information management features. It supports online research for specifiers and helps manufacturers present their offerings more effectively, with the goal of making it quicker and easier to identify suitable products for any project, regardless of brand or reputation.

SpecifiedBy operates a database and specification library for building products and materials, connecting manufacturers with specifiers and enabling professionals to search, compare, and manage product information. The platform aggregates relevant data to support decision-making and aims to streamline the product selection process by offering modern search tools and information management features. It supports online research for specifiers and helps manufacturers present their offerings more effectively, with the goal of making it quicker and easier to identify suitable products for any project, regardless of brand or reputation.

FusionIP is a company focused on commercializing university-owned research from two prominent UK institutions, The University of Sheffield and Cardiff University. By forming exclusive partnerships with these universities, FusionIP has the rights to develop innovative technologies in various fields, including clean energy, electronics, engineering, and medicine. The company transforms this world-class research into viable businesses by creating a diverse portfolio of companies. Additionally, FusionIP has previously engaged in funding universities to support the development of intellectual property, securing a share of the earnings generated from these rights. Through these initiatives, FusionIP aims to bridge the gap between academic research and market-ready solutions.

SpecifiedBy operates a database and specification library for building products and materials, connecting manufacturers with specifiers and enabling professionals to search, compare, and manage product information. The platform aggregates relevant data to support decision-making and aims to streamline the product selection process by offering modern search tools and information management features. It supports online research for specifiers and helps manufacturers present their offerings more effectively, with the goal of making it quicker and easier to identify suitable products for any project, regardless of brand or reputation.

Oxford Nanopore Technologies Limited is a biotechnology company specializing in the development and commercialization of nanopore-based sequencing technology for the analysis of DNA, RNA, proteins, and small molecules. Its innovative product lineup includes the portable MinION device, the benchtop PromethION, and the GridION system, all of which enable real-time data streaming and scalable sequencing for a variety of applications in scientific research, personalized medicine, environmental monitoring, and agriculture. The Flongle offers smaller, on-demand sequencing solutions, catering to users requiring rapid insights. Operating in over 80 countries, Oxford Nanopore's technology is designed for accessibility and ease of use, featuring straightforward library preparation and automated solutions. The company maintains a robust patent portfolio, supporting its ongoing research and development in both biological and solid-state nanopore technologies. Founded in 2005 and based in Oxford, United Kingdom, Oxford Nanopore Technologies also has offices in multiple countries, including the United States, China, and Germany.

Ubiquigent Limited is a biotechnology company based in Dundee, United Kingdom, founded in 2009. It specializes in the development and supply of high-quality reagents, kits, and drug discovery assay development services, focusing on the ubiquitin and ubiquitin-like signaling systems. The company provides protein degradation-focused drug discovery services and designs novel deubiquitylase (DUB) enzyme inhibitors as potential therapeutics for addressing unmet medical needs. Ubiquigent collaborates with both academic and pharmaceutical researchers, supporting fundamental scientific discovery and the exploration of innovative drug candidates targeting DUBs. Its hybrid business model emphasizes the generation of intellectual property while maintaining an internal pipeline of drug discovery programs aimed at optimizing compounds for critical therapeutic areas.

Deltasight is a data company that develops a data platform for analyzing, visualizing, and predicting global innovation and IP. It offers practical and easy-to-use tools for global innovation and intellectual property analysis and visualization. The said platform generally collects data from 90 countries. Its products visually map trends and connections between companies, people, and inventions, giving businesses, R&D and technology transfer professionals a better understanding of global innovation. Its platform builds upon Deltasight’s proprietary Innovation Graph, which provides easy exploration of Innovation Profiles for inventions, people, organizations, and sectors. Its main customers include: private equity firms, technology companies, IP firms, and universities. Deltasight was founded in 2011 and is headquartered in Newcastle Upon Tyne. It is currently in private beta.

Xeros Technology Group plc specializes in developing and commercializing polymer-based technologies aimed at reducing water usage in cleaning processes across various sectors, including fabric and garment manufacturing, as well as industrial and domestic laundry. The company has created innovative products such as XOrbs, which utilize polymer technology to effectively remove dirt and stains with minimal water, and XDrum, designed for fabric and garment manufacturing applications. Additionally, it offers XFiltra, a system that facilitates the easy disposal of collected fibers by de-watering filtered materials. Originating from research by Professor Stephen Burkinshaw at the University of Leeds, Xeros's patented polymer bead cleaning system demonstrates significant potential for cost savings and environmental benefits in commercial laundry and other industries like leather processing and metal cleaning. Based in Rotherham, United Kingdom, Xeros continues to expand its operations in Europe and North America.

Magnomatics Limited is a technology engineering company based in Sheffield, United Kingdom, founded in 2006 as a spin-out from the University of Sheffield. Specializing in proprietary magnetic gear technology, Magnomatics develops innovative products such as the Pseudo Direct Drive, a high torque low-speed motor and generator suitable for various applications including actuation, fan motors, marine propulsion, and wind power. Additionally, the company offers MAGSPLIT, a power-split continuously variable transmission solution designed for blended hybrid powertrains and ancillary drives. Serving diverse sectors such as oil and gas, automotive, aerospace, marine propulsion, renewable energy, and rail traction, Magnomatics aims to provide efficient alternatives to traditional mechanical gears, thereby lowering operating costs and reducing carbon emissions in the transport and energy industries.

Karus Therapeutics Limited is a biopharmaceutical company based in Oxfordshire, United Kingdom, that specializes in the development of small molecule drugs aimed at treating cancer and immune/inflammatory disorders. Founded in 2005, the company focuses on designing innovative, molecular-targeted therapies. Its portfolio includes orally-active drugs such as KA2237, a dual-selective inhibitor of PI3K isoforms effective against hematological and solid tumors, and KA2507, which targets HDAC6 for tumors expressing PD-L1. By combining targeted therapy with immunotherapeutic activity, Karus Therapeutics aims to provide effective treatment options for a diverse range of cancers.

MedaPhor Limited is an e-learning company based in Cardiff, United Kingdom, that specializes in creating training products for postgraduate medical professionals. The company focuses on enhancing ultrasound examination techniques through its innovative simulation technology solutions. MedaPhor's offerings include Blue Phantom, which provides ultrasound phantoms for hands-on simulation training in gynaecology and obstetrics, and True Anatomy, an endovaginal training model designed for ultrasound simulation. Additionally, MedaPhor develops models for intrauterine pregnancy, ectopic pregnancy, and general pathology, contributing to the advancement of medical education and training. Established in 2004, MedaPhor aims to improve the skills and knowledge of healthcare practitioners through its comprehensive training solutions.

Oxford Nanopore Technologies Limited is a biotechnology company specializing in the development and commercialization of nanopore-based sequencing technology for the analysis of DNA, RNA, proteins, and small molecules. Its innovative product lineup includes the portable MinION device, the benchtop PromethION, and the GridION system, all of which enable real-time data streaming and scalable sequencing for a variety of applications in scientific research, personalized medicine, environmental monitoring, and agriculture. The Flongle offers smaller, on-demand sequencing solutions, catering to users requiring rapid insights. Operating in over 80 countries, Oxford Nanopore's technology is designed for accessibility and ease of use, featuring straightforward library preparation and automated solutions. The company maintains a robust patent portfolio, supporting its ongoing research and development in both biological and solid-state nanopore technologies. Founded in 2005 and based in Oxford, United Kingdom, Oxford Nanopore Technologies also has offices in multiple countries, including the United States, China, and Germany.

Deltasight is a data company that develops a data platform for analyzing, visualizing, and predicting global innovation and IP. It offers practical and easy-to-use tools for global innovation and intellectual property analysis and visualization. The said platform generally collects data from 90 countries. Its products visually map trends and connections between companies, people, and inventions, giving businesses, R&D and technology transfer professionals a better understanding of global innovation. Its platform builds upon Deltasight’s proprietary Innovation Graph, which provides easy exploration of Innovation Profiles for inventions, people, organizations, and sectors. Its main customers include: private equity firms, technology companies, IP firms, and universities. Deltasight was founded in 2011 and is headquartered in Newcastle Upon Tyne. It is currently in private beta.

Surrey NanoSystems manufactures nanoscale materials for engineering and product applications, most notably Vantablack, a super-black coating applied to surfaces via vacuum-deposition and post-processing techniques. The coating suppresses stray light and is used in architectural lighting, aesthetic applications, calibration sources, sensors, telescopes, IR imaging systems, spectroscopy, automotive optics, cinematography optics, satellite calibration sources, camera lenses, and related applications. Originating as CEVP, the company began operating in 2006 and is headquartered in Newhaven, United Kingdom.

Seren Photonics Limited specializes in the development and manufacture of semi-polar and non-polar Gallium Nitride (GaN) templates, which are essential for light-emitting diodes (LEDs), lasers, vertical-cavity surface-emitting lasers (VCSELs), and power switches. Based in Bridgend, United Kingdom, the company employs a proprietary manufacturing process to produce these templates, specifically growing semi-polar GaN on m-plane sapphire and non-polar GaN on r-plane sapphire. Their innovative technology significantly enhances light intensity in high-brightness LEDs, achieving increases in light generation ranging from 100% to 900% compared to untreated diodes. Founded in 2009, Seren Photonics has positioned itself to serve various lighting markets, including backlighting for laptops and televisions, signage, and architectural lighting. As of November 2016, it operates as a subsidiary of Fusion IP Sheffield Limited.

First Light Fusion Limited is a UK-based company that specializes in researching advanced implosion processes aimed at electricity generation through inertial confinement fusion. Founded in 2011 as a spin-out from the University of Oxford, the company focuses on harnessing fundamental physics to explore various innovative energy generation methods. It employs a team of engineers and physicists who engage in theoretical analysis, detailed numerical simulations, and experimental validation to develop new energy sources. First Light Fusion collaborates closely with several academic institutions, including the University of Oxford, Warwick University, University College London, and Imperial College London. The company, originally named Oxyntix Ltd., rebranded in June 2014 to reflect its focus on fusion energy research.

Oxford Nanopore Technologies Limited is a biotechnology company specializing in the development and commercialization of nanopore-based sequencing technology for the analysis of DNA, RNA, proteins, and small molecules. Its innovative product lineup includes the portable MinION device, the benchtop PromethION, and the GridION system, all of which enable real-time data streaming and scalable sequencing for a variety of applications in scientific research, personalized medicine, environmental monitoring, and agriculture. The Flongle offers smaller, on-demand sequencing solutions, catering to users requiring rapid insights. Operating in over 80 countries, Oxford Nanopore's technology is designed for accessibility and ease of use, featuring straightforward library preparation and automated solutions. The company maintains a robust patent portfolio, supporting its ongoing research and development in both biological and solid-state nanopore technologies. Founded in 2005 and based in Oxford, United Kingdom, Oxford Nanopore Technologies also has offices in multiple countries, including the United States, China, and Germany.

Activiomics Ltd. is a biotechnology company specializing in biomarker technology and phosphoproteomics solutions aimed at enhancing biomarker discovery and drug candidate profiling. The company has developed a patented mass spectrometry-based technology that facilitates the global quantitative analysis of phosphorylation sites, which are critical mediators of cellular processes. This technology, known as TIQUAS (Targeted In-depth QUAntification of cell Signalling), allows for the quantification of thousands of phosphorylation events from tissue samples. By identifying and quantifying proteins and phosphoproteins that correlate with disease progression and drug administration, Activiomics aims to transform the development of diagnostics and therapeutic strategies.

Crysalin Limited is a research and development company based in London, United Kingdom, founded in June 2007. It specializes in crysalin lattice technology, which has been developed from patented research conducted at the Oxford University Laboratory of Molecular Biophysics since 2002. The company's primary focus is on crysalins, a protein-based nanotechnology that significantly enhances protein structure determination, particularly for challenging macromolecular targets such as membrane proteins and flexible soluble proteins. By imposing order on these complex structures, crysalins enable advanced imaging techniques like X-ray and electron microscopy to accurately resolve three-dimensional molecular structures. In addition to protein structure determination, Crysalin's technology holds potential applications in biosensor development and optoelectronics, expanding its impact in the field of molecular research.

Seren Photonics Limited specializes in the development and manufacture of semi-polar and non-polar Gallium Nitride (GaN) templates, which are essential for light-emitting diodes (LEDs), lasers, vertical-cavity surface-emitting lasers (VCSELs), and power switches. Based in Bridgend, United Kingdom, the company employs a proprietary manufacturing process to produce these templates, specifically growing semi-polar GaN on m-plane sapphire and non-polar GaN on r-plane sapphire. Their innovative technology significantly enhances light intensity in high-brightness LEDs, achieving increases in light generation ranging from 100% to 900% compared to untreated diodes. Founded in 2009, Seren Photonics has positioned itself to serve various lighting markets, including backlighting for laptops and televisions, signage, and architectural lighting. As of November 2016, it operates as a subsidiary of Fusion IP Sheffield Limited.

Xeros Technology Group plc specializes in developing and commercializing polymer-based technologies aimed at reducing water usage in cleaning processes across various sectors, including fabric and garment manufacturing, as well as industrial and domestic laundry. The company has created innovative products such as XOrbs, which utilize polymer technology to effectively remove dirt and stains with minimal water, and XDrum, designed for fabric and garment manufacturing applications. Additionally, it offers XFiltra, a system that facilitates the easy disposal of collected fibers by de-watering filtered materials. Originating from research by Professor Stephen Burkinshaw at the University of Leeds, Xeros's patented polymer bead cleaning system demonstrates significant potential for cost savings and environmental benefits in commercial laundry and other industries like leather processing and metal cleaning. Based in Rotherham, United Kingdom, Xeros continues to expand its operations in Europe and North America.

Karus Therapeutics Limited is a biopharmaceutical company based in Oxfordshire, United Kingdom, that specializes in the development of small molecule drugs aimed at treating cancer and immune/inflammatory disorders. Founded in 2005, the company focuses on designing innovative, molecular-targeted therapies. Its portfolio includes orally-active drugs such as KA2237, a dual-selective inhibitor of PI3K isoforms effective against hematological and solid tumors, and KA2507, which targets HDAC6 for tumors expressing PD-L1. By combining targeted therapy with immunotherapeutic activity, Karus Therapeutics aims to provide effective treatment options for a diverse range of cancers.

Oxford Nanopore Technologies Limited is a biotechnology company specializing in the development and commercialization of nanopore-based sequencing technology for the analysis of DNA, RNA, proteins, and small molecules. Its innovative product lineup includes the portable MinION device, the benchtop PromethION, and the GridION system, all of which enable real-time data streaming and scalable sequencing for a variety of applications in scientific research, personalized medicine, environmental monitoring, and agriculture. The Flongle offers smaller, on-demand sequencing solutions, catering to users requiring rapid insights. Operating in over 80 countries, Oxford Nanopore's technology is designed for accessibility and ease of use, featuring straightforward library preparation and automated solutions. The company maintains a robust patent portfolio, supporting its ongoing research and development in both biological and solid-state nanopore technologies. Founded in 2005 and based in Oxford, United Kingdom, Oxford Nanopore Technologies also has offices in multiple countries, including the United States, China, and Germany.

Polar OLED Ltd. is a company based in Leeds, United Kingdom, specializing in the development and supply of liquid crystal-based polymer materials for optoelectronic devices. Established in 2008 as a spin-out from the University of Hull, Polar OLED focuses on innovative materials that serve various applications, including organic light-emitting diodes (OLED) for displays and lighting, as well as backlighting for liquid crystal displays (LCD) and photovoltaics. The company's offerings include photoalignment layers, insoluble charge transport layers, and light-emitting polymers, which are essential for enhancing the performance and functionality of electronic products such as televisions and laptop displays.

Surrey NanoSystems manufactures nanoscale materials for engineering and product applications, most notably Vantablack, a super-black coating applied to surfaces via vacuum-deposition and post-processing techniques. The coating suppresses stray light and is used in architectural lighting, aesthetic applications, calibration sources, sensors, telescopes, IR imaging systems, spectroscopy, automotive optics, cinematography optics, satellite calibration sources, camera lenses, and related applications. Originating as CEVP, the company began operating in 2006 and is headquartered in Newhaven, United Kingdom.

Xeros Technology Group plc specializes in developing and commercializing polymer-based technologies aimed at reducing water usage in cleaning processes across various sectors, including fabric and garment manufacturing, as well as industrial and domestic laundry. The company has created innovative products such as XOrbs, which utilize polymer technology to effectively remove dirt and stains with minimal water, and XDrum, designed for fabric and garment manufacturing applications. Additionally, it offers XFiltra, a system that facilitates the easy disposal of collected fibers by de-watering filtered materials. Originating from research by Professor Stephen Burkinshaw at the University of Leeds, Xeros's patented polymer bead cleaning system demonstrates significant potential for cost savings and environmental benefits in commercial laundry and other industries like leather processing and metal cleaning. Based in Rotherham, United Kingdom, Xeros continues to expand its operations in Europe and North America.

Oxford Nanopore Technologies Limited is a biotechnology company specializing in the development and commercialization of nanopore-based sequencing technology for the analysis of DNA, RNA, proteins, and small molecules. Its innovative product lineup includes the portable MinION device, the benchtop PromethION, and the GridION system, all of which enable real-time data streaming and scalable sequencing for a variety of applications in scientific research, personalized medicine, environmental monitoring, and agriculture. The Flongle offers smaller, on-demand sequencing solutions, catering to users requiring rapid insights. Operating in over 80 countries, Oxford Nanopore's technology is designed for accessibility and ease of use, featuring straightforward library preparation and automated solutions. The company maintains a robust patent portfolio, supporting its ongoing research and development in both biological and solid-state nanopore technologies. Founded in 2005 and based in Oxford, United Kingdom, Oxford Nanopore Technologies also has offices in multiple countries, including the United States, China, and Germany.